Targeting BMI-1 with PLGA–PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cancer Nanotechnology 12 (2021), 5, 1-20
- Ereignis
-
Veröffentlichung
- (wo)
-
Münster
- (wer)
-
Universitäts- und Landesbibliothek Münster
- (wann)
-
2023
- Urheber
-
Poonaki, Elham
Ariakia, Fatemeh
Jalili‑Nik, Mohammad
Shafiee Ardestani, Mehdi
Tondro, Gholamhossein
Samini, Fariborz
Ghasemi, Sepideh
Sahab‑Negah, Sajad
Gorji, Ali
- DOI
-
10.17879/70049488425
- URN
-
urn:nbn:de:hbz:6-60049446360
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Poonaki, Elham
- Ariakia, Fatemeh
- Jalili‑Nik, Mohammad
- Shafiee Ardestani, Mehdi
- Tondro, Gholamhossein
- Samini, Fariborz
- Ghasemi, Sepideh
- Sahab‑Negah, Sajad
- Gorji, Ali
- Universitäts- und Landesbibliothek Münster
Entstanden
- 2023
Ähnliche Objekte (12)
Targeting BMI-1 with PLGA–PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells
PEG–PLGA nanoparticles for encapsulating ciprofloxacin
An ellagitannin-loaded CS-PEG decorated PLGA nano-prototype promotes cell cycle arrest in colorectal cancer cells
Optimization and in Vitro Evaluation of Injectable Sustained-Release of Levothyroxine Using PLGA-PEG-PLGA
PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells
SN38-PEG-PLGA-verapamil nanoparticles inhibit proliferation and downregulate drug transporter ABCG2 gene expression in colorectal cancer cells
Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs
Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations
Aptamer-labeled PLGA nanoparticles for targeting cancer cells
Attenuation of skin injury by a MARCO targeting PLGA nanoparticle
Targeting BMI-1 with PLGA–PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells
PEG–PLGA nanoparticles for encapsulating ciprofloxacin
An ellagitannin-loaded CS-PEG decorated PLGA nano-prototype promotes cell cycle arrest in colorectal cancer cells
Optimization and in Vitro Evaluation of Injectable Sustained-Release of Levothyroxine Using PLGA-PEG-PLGA
PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells
SN38-PEG-PLGA-verapamil nanoparticles inhibit proliferation and downregulate drug transporter ABCG2 gene expression in colorectal cancer cells
Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs
Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations
Aptamer-labeled PLGA nanoparticles for targeting cancer cells
Attenuation of skin injury by a MARCO targeting PLGA nanoparticle
Targeting BMI-1 with PLGA–PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells
PEG–PLGA nanoparticles for encapsulating ciprofloxacin
An ellagitannin-loaded CS-PEG decorated PLGA nano-prototype promotes cell cycle arrest in colorectal cancer cells
Optimization and in Vitro Evaluation of Injectable Sustained-Release of Levothyroxine Using PLGA-PEG-PLGA
PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells
SN38-PEG-PLGA-verapamil nanoparticles inhibit proliferation and downregulate drug transporter ABCG2 gene expression in colorectal cancer cells
Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs
Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations
Aptamer-labeled PLGA nanoparticles for targeting cancer cells